his and hers semaglutide Hims & makes deal with Novo in obesity strategy shift Novo Nordisk calls out dangers

No one knows for sure, but millions of older adults may likely be left in a lurch if they can no longer count on subsidized access to what many describe as a life-changing medication

Type 2 diabetes is an established risk factor for developing dementia, including Alzheimer's disease

Broader Oral Access: Compounded oral choices available in more states when appropriate

FIGURE 13 4 Discussions Over the years following its discovery, GLP-1 has garnered significant attention for its incretin effect on glucoregulation in the management of T2DM, including its role in improving cardiovascular, respiratory, and renal functions (Singh et al., 2025b)

Interestingly, Yang et al